Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.

Wu L, Chaffee KG, Parker AS, Sicotte H, Petersen GM.

Tumour Biol. 2015 Apr 23. [Epub ahead of print]

PMID:
25900876
2.

Prospective Evaluation of the Association of Adherent Perinephric Fat With Perioperative Outcomes of Robotic-assisted Partial Nephrectomy.

Davidiuk AJ, Parker AS, Thomas CS, Heckman MG, Custer K, Thiel DD.

Urology. 2015 Apr;85(4):836-42. doi: 10.1016/j.urology.2014.12.017. Epub 2015 Feb 7.

PMID:
25669734
3.

Whole-exome sequencing as a diagnostic tool in a family with episodic ataxia type 1.

Tacik P, Guthrie KJ, Strongosky AJ, Broderick DF, Riegert-Johnson DL, Tang S, El-Khechen D, Parker AS, Ross OA, Wszolek ZK.

Mayo Clin Proc. 2015 Mar;90(3):366-71. doi: 10.1016/j.mayocp.2015.01.001. Epub 2015 Feb 3.

PMID:
25659636
4.

Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.

Jambusaria-Pahlajani A, Karia PS, Parker AS, Schmults CD.

J Surg Oncol. 2015 Mar 15;111(4):483-4. doi: 10.1002/jso.23841. Epub 2014 Dec 9. No abstract available.

PMID:
25492622
5.

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.

Ho TH, Kapur P, Joseph RW, Serie DJ, Eckel-Passow JE, Parasramka M, Cheville JC, Wu KJ, Frenkel E, Rakheja D, Stefanius K, Brugarolas J, Parker AS.

Urol Oncol. 2015 Jan;33(1):23.e9-14. doi: 10.1016/j.urolonc.2014.10.014. Epub 2014 Nov 24.

PMID:
25465300
6.

Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy.

Davidiuk AJ, Parker AS, Thomas CS, Leibovich BC, Castle EP, Heckman MG, Custer K, Thiel DD.

Eur Urol. 2014 Dec;66(6):1165-71. doi: 10.1016/j.eururo.2014.08.054. Epub 2014 Sep 2.

PMID:
25192968
7.

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.

Eckel-Passow JE, Igel DA, Serie DJ, Joseph RW, Ho TH, Cheville JC, Parker AS.

Urol Oncol. 2015 Feb;33(2):68.e17-23. doi: 10.1016/j.urolonc.2014.07.019. Epub 2014 Aug 28.

PMID:
25175426
8.

Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.

Tavlarides AM, Ames SC, Thiel DD, Diehl NN, Parker AS.

Psychooncology. 2015 Apr;24(4):451-7. doi: 10.1002/pon.3605. Epub 2014 Jun 21.

PMID:
24953309
9.

Genomic medicine and incidental findings: balancing actionability and patient autonomy.

McCormick JB, Sharp RR, Farrugia G, Lindor NM, Babovic-Vuksanovic D, Borad MJ, Bryce AH, Caselli RJ, Ferber MJ, Johnson KJ, Lazaridis KN, McWilliams RR, Murray JA, Parker AS, Schahl KA, Wieben ED.

Mayo Clin Proc. 2014 Jun;89(6):718-21. doi: 10.1016/j.mayocp.2014.04.008. No abstract available.

PMID:
24943691
10.

External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort.

Chen LM, Chang M, Dai Y, Chai KX, Dyrskj√łt L, Sanchez-Carbayo M, Szarvas T, Zwarthoff EC, Lokeshwar V, Jeronimo C, Parker AS, Ross S, Borre M, Orntoft TF, Jaeger T, Beukers W, Lopez LE, Henrique R, Young PR, Urquidi V, Goodison S, Rosser CJ.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1804-12. doi: 10.1158/1055-9965.EPI-14-0029. Epub 2014 Jun 11.

PMID:
24920641
11.

Intravesical ALT-803 and BCG treatment reduces tumor burden in a carcinogen induced bladder cancer rat model; a role for cytokine production and NK cell expansion.

Gomes-Giacoia E, Miyake M, Goodison S, Sriharan A, Zhang G, You L, Egan JO, Rhode PR, Parker AS, Chai KX, Wong HC, Rosser CJ.

PLoS One. 2014 Jun 4;9(6):e96705. doi: 10.1371/journal.pone.0096705. eCollection 2014.

12.

Re: Samira A. Brooks, A. Rose Brannon, Joel S. Parker, et al. Clear Code34: a prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol 2014;66:77-84.

Parker AS, Leibovich BC, Eckel-Passow JE, Cheville JC.

Eur Urol. 2014 Nov;66(5):e90-1. doi: 10.1016/j.eururo.2014.05.009. Epub 2014 May 27. No abstract available.

PMID:
24877662
13.

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma.

Eckel-Passow JE, Serie DJ, Bot BM, Joseph RW, Cheville JC, Parker AS.

BMC Urol. 2014 Jan 31;14:14. doi: 10.1186/1471-2490-14-14.

14.

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

Parker AS, Eckel-Passow JE, Serie D, Hilton T, Parasramka M, Joseph RW, Wu KJ, Cheville JC, Leibovich BC.

Eur Urol. 2014 Nov;66(5):929-35. doi: 10.1016/j.eururo.2013.12.017. Epub 2013 Dec 25.

PMID:
24388441
15.

Somatic expression of ENRAGE is associated with obesity status among patients with clear cell renal cell carcinoma.

Eckel-Passow JE, Serie DJ, Bot BM, Joseph RW, Hart SN, Cheville JC, Parker AS.

Carcinogenesis. 2014 Apr;35(4):822-7. doi: 10.1093/carcin/bgt485. Epub 2013 Dec 28.

16.

Evaluation of awareness of risk factors for kidney cancer among patients presenting to a urology clinic.

Parker AS, Arnold ML, Diehl ND, Hassan L, Thiel DD.

Scand J Urol. 2014 Jun;48(3):239-44. doi: 10.3109/21681805.2013.863803. Epub 2013 Dec 12.

PMID:
24328689
17.

Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.

Arnold ML, Thiel DD, Diehl N, Wu KJ, Ames S, Parker AS.

BMC Urol. 2013 Oct 22;13:52. doi: 10.1186/1471-2490-13-52.

18.

Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate Cancer.

Heckman MG, Tzou KS, Parker AS, Pisansky TM, Schild SE, Hilton TW, Patel VN, Pelaez L, Khor LY, Peterson JL, Daugherty LC, Vallow LA, Pollack A, Buskirk SJ.

J Radiat Oncol. 2013 Sep 1;2(3):309-314.

19.

Maximum tumor diameter is not an accurate predictor of renal cell carcinoma tumor volume.

Thiel DD, Jorns J, Lohse CM, Cheville JC, Thompson RH, Parker AS.

Scand J Urol. 2013 Dec;47(6):472-5. doi: 10.3109/21681805.2013.814071. Epub 2013 Jul 24.

PMID:
23883351
20.

Age-period-cohort analysis of renal cell carcinoma in United States adults.

Tyson MD, Humphreys MR, Parker AS, Thiel DD, Joseph RW, Andrews PE, Castle EP.

Urology. 2013 Jul;82(1):43-7. doi: 10.1016/j.urology.2013.02.065. Epub 2013 May 22.

PMID:
23706585
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk